This procedural ruling does not change the fundamental risk profile of the trade-secret litigation. Monitor for upcoming dispositive motions or trial dates that could create material exposure. The denial of discovery is a minor setback but not a case-ending event.
Price Chart
Executive Summary
OraSure's motion to reopen fact discovery in its trade-secret litigation against NowDiagnostics was denied by the Eastern District of Pennsylvania. The court adopted the Special Master's recommendation that OraSure lacked diligence and already has sufficient evidence to challenge the opposing declaration. This is a procedural loss that keeps the case on track toward trial or settlement without materially altering the litigation landscape for OraSure.
Court Ruling Details
Key Facts
- OraSure's motion to reopen fact discovery for a limited purpose was denied.
- The court adopted the Special Master's Report and Recommendation finding OraSure lacked diligence.
- OraSure did not file objections to the Special Master's recommendation.
- The case involves competing trade-secret claims over diagnostic test designs.
- OraSure's motion to file under seal was also denied.
Financial Impact
No monetary damages or financial exposure stated in the ruling.
Risk Factors
- Adverse ruling at trial or summary judgment on trade-secret counterclaims could create financial liability.
- Continued litigation costs without resolution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-e75c21b2df-OSUR |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 23, 2026 10w ago | Court Ruling | $4.03 $3.74 | ▼ −7.20% | ▼ −10.50% | $3.99 (−0.99%) |
Jun 12, 2026 16w ago | Institutional Cluster | $4.18 $4.30 | ▲ +2.75% | ▲ +0.97% | $3.99 (−4.55%) |
Jun 3, 2026 17w ago | 8-K | $4.17 $4.35 | ▲ +4.32% | ▲ +5.69% | $3.99 (−4.32%) |
May 6, 2026 21w ago | 8-K | $3.13 $3.95 | ▼ −26.20% | ▼ −23.06% | $3.99 (−27.48%) |
Apr 22, 2026 23w ago | Press Release | $3.05 $3.07 | ▼ −0.66% | ▲ +3.98% | $3.99 (−30.82%) |
Apr 17, 2026 24w ago | DEFA14A | $3.16 $2.95 | ▼ −6.65% | ▼ −12.02% | $3.99 (+26.27%) |
Apr 17, 2026 24w ago | DEFA14A | $3.16 $2.95 | ▼ −6.65% | ▼ −12.02% | $3.99 (+26.27%) |
Apr 17, 2026 24w ago | 8-K | $3.16 $2.95 | ▼ −6.65% | ▼ −12.02% | $3.99 (+26.27%) |
Mar 20, 2026 28w ago | Insider Cluster | $2.95 $3.00 | ▲ +1.53% | ▼ −7.79% | $3.99 (+35.25%) |
Mar 17, 2026 28w ago | DEFA14A | $2.90 $3.21 | ▲ +10.69% | ▲ +4.64% | $3.99 (+37.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access